These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 11724358

  • 1. Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesions.
    Scovassi AL, Pellegata NS, Di Stefano L, Padovan L, Negri C, Prosperi E, Riva F, Ciomei M, Ranzani GN.
    Anticancer Res; 2001; 21(4A):2803-8. PubMed ID: 11724358
    [Abstract] [Full Text] [Related]

  • 2. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F, Bae I, Fornace AJ, Pommier Y.
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [Abstract] [Full Text] [Related]

  • 3. Complex response of breast epithelial cell lines to topoisomerase inhibitors.
    Davis PL, Shaiu WL, Scott GL, Iglehart JD, Hsieh TS, Marks JR.
    Anticancer Res; 1998; 18(4C):2919-32. PubMed ID: 9713486
    [Abstract] [Full Text] [Related]

  • 4. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH, Wong BC, Lin MC, Zhu GH, Kung HF, Jiang SH, Yang D, Lam SK.
    Oncogene; 2001 Nov 29; 20(55):8009-18. PubMed ID: 11753684
    [Abstract] [Full Text] [Related]

  • 5. Induction of apoptosis and cell cycle arrest in glioma cells by GL331 (a topoisomerase II inhibitor).
    Chen Y, Su YH, Wang CH, Wu JM, Chen JC, Tseng SH.
    Anticancer Res; 2005 Nov 29; 25(6B):4203-8. PubMed ID: 16309217
    [Abstract] [Full Text] [Related]

  • 6. DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells.
    Horiguchi-Yamada J, Fukumi S, Saito S, Nakayama R, Iwase S, Yamada H.
    Anticancer Res; 2002 Nov 29; 22(6C):3827-32. PubMed ID: 12553001
    [Abstract] [Full Text] [Related]

  • 7. Cellular response to etoposide treatment.
    Montecucco A, Biamonti G.
    Cancer Lett; 2007 Jul 08; 252(1):9-18. PubMed ID: 17166655
    [Abstract] [Full Text] [Related]

  • 8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 08; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 9. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F, Knobbe CB, Frank B, Wolburg H, Weller M.
    Oncol Rep; 2008 Apr 08; 19(4):1061-6. PubMed ID: 18357397
    [Abstract] [Full Text] [Related]

  • 10. Enhancing the antiproliferative effect of topoisomerase II inhibitors using a polypeptide inhibitor of c-Myc.
    Bidwell GL, Raucher D.
    Biochem Pharmacol; 2006 Jan 12; 71(3):248-56. PubMed ID: 16316634
    [Abstract] [Full Text] [Related]

  • 11. Apoptosis of androgen-independent mammary and prostate cell lines induced by topoisomerase inhibitors: common pathway of gene regulation.
    Furuya Y, Ohta S, Ito H.
    Anticancer Res; 1997 Jan 12; 17(3C):2089-93. PubMed ID: 9216669
    [Abstract] [Full Text] [Related]

  • 12. G2 arrest in response to topoisomerase II inhibitors: the role of p53.
    Clifford B, Beljin M, Stark GR, Taylor WR.
    Cancer Res; 2003 Jul 15; 63(14):4074-81. PubMed ID: 12874009
    [Abstract] [Full Text] [Related]

  • 13. Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells.
    Chiu CC, Li CH, Ung MW, Fuh TS, Chen WL, Fang K.
    Cancer Lett; 2005 Jun 08; 223(2):249-58. PubMed ID: 15896459
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.
    Richie JP.
    J Urol; 2005 Sep 08; 174(3):931-2. PubMed ID: 16093994
    [No Abstract] [Full Text] [Related]

  • 15. Cycloheximide protects HepG2 cells from serum withdrawal-induced apoptosis by decreasing p53 and phosphorylated p53 levels.
    Bai J, Cederbaum AI.
    J Pharmacol Exp Ther; 2006 Dec 08; 319(3):1435-43. PubMed ID: 16971506
    [Abstract] [Full Text] [Related]

  • 16. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM, Hulscher TM, Schrier SM, van Houten VM, Pinedo HM, Boven E.
    Gynecol Oncol; 2002 Mar 08; 84(3):404-12. PubMed ID: 11855878
    [Abstract] [Full Text] [Related]

  • 17. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT, Gershenson DM, Tortolero-Luna G, Ramondetta LM, Fightmaster D, Wharton JT, Wolf JK.
    Gynecol Oncol; 2001 Dec 08; 83(3):543-8. PubMed ID: 11733969
    [Abstract] [Full Text] [Related]

  • 18. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs.
    Potter AJ, Rabinovitch PS.
    Mutat Res; 2005 May 02; 572(1-2):27-44. PubMed ID: 15790488
    [Abstract] [Full Text] [Related]

  • 19. Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines.
    Brown GA, McPherson JP, Gu L, Hedley DW, Toso R, Deuchars KL, Freedman MH, Goldenberg GJ.
    Cancer Res; 1995 Jan 01; 55(1):78-82. PubMed ID: 7805045
    [Abstract] [Full Text] [Related]

  • 20. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
    Baptiste N, Friedlander P, Chen X, Prives C.
    Oncogene; 2002 Jan 03; 21(1):9-21. PubMed ID: 11791172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.